Mr. Bonfiglio is the Founder & Managing Partner of Proteus, LLC – an investment and advisory firm focused solely on regenerative medicine. Proteus provides fund management, consulting, and investment banking services to the regenerative medicine industry. Proteus wo…more ›

I am devoted to improving care for leukemia patients, including clinical service (60%), administration (5%), clinical research (25%), and teaching (10%). I attend on our inpatient Leukemia and Bone Marrow Transplantation service 3 months yearly and 6 outpatient session…more ›

Dr. Hariri has combined his unique skills with the inventiveness of a proven serial entrepreneur in two distinct technology sectors; biomedical technology and aerospace. The Founder and Chief Executive Officer of Celgene Cellular Therapeutics, one of the world's lar…more ›

Economics Degree from Universidade Candido Mendes, Brazil, and further education at INSEAD (France) and at the Wharton School (USA). Held senior positions at Pepsico (Business Develpoment Director), Globocabo Brazil (CFO), Arisco Brazil (CFO) and CBCC Outsourcing Brazil…more ›

Dr. Colleen Delaney is an Associate Member of the Fred Hutchinson Cancer Research Center (FHCRC) Clinical Research Division and an Associate Professor at the University of Washington in the Department of Pediatrics, Division of Pediatric Hematology/Oncology. She is an a…more ›

Dr Casper is the Camille Dan Family Research Chair in Translational Cell Biology and a Senior Investigator in the Samuel Lunenfeld Research Institute at Mount Sinai Hospital. Dr Casper is also Professor of the Division of Reproductive Endocrinology and Infertility in t…more ›

Yong Zhao, MD, PhD, Assistant Professor, University of Illinois at Chicago. He received his Postdoc training in Stem Cell Biology at University of Chicago/Argonne National Laboratory, (2000 - 2004); He received his PhD in Immunology at Shanghai Second Military Medical U…more ›

Dr. Charles S. Cox, Jr., is the Children’s Fund, Inc. Distinguished Professor of Pediatric Surgery and directs the Pediatric Surgical Translational Laboratories and Pediatric Program in Regenerative Medicine at the University of Texas Medical School at Houston. He dire…more ›

Professor Zandstra’s research focuses on understanding how complex communication networks between stem cells and their progeny influence differentiation, and is designing bioreactors specifically capable of controlling cell fate. Dr. Zandstra graduated with a Bachelor o…more ›

Dana is the Managing Partner of Boston Millennia Partners. Prior to founding Boston Millennia Partners, Dana co-founded Boston Capital Ventures in 1982. Before that, he worked as a Senior Consultant at Braxton Associates, an international strategic planning firm that wa…more ›

Michael Boo has served as Chief Strategy Officer of National Marrow Donor Program since October, 2001. He is responsible for strategic planning at the NMDP and guides public policy matters for the company. He also manages the international relationship development and i…more ›

Carol Taylor, Ph.D., joined the Puget Sound Blood Center’s Cord Blood Program as director in July, 2011. Prior to that time, Dr. Taylor was instrumental in the creation of the Nucleic Acid Testing (NAT) Lab for the Blood Center and oversaw its growth and evolution. Sh…more ›